PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127883
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2127883
Breast Imaging Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of breast imaging Market
The global breast imaging market was valued at USD 6.03 billion in 2025 and is projected to grow from USD 6.66 billion in 2026 to USD 10.63 billion by 2034, registering a CAGR of 6.4% during the forecast period. North America dominated the global market with a 43.78% market share in 2025, supported by high screening awareness, advanced healthcare infrastructure, and widespread adoption of digital breast imaging technologies.
Breast imaging plays a critical role in the early detection, diagnosis, and monitoring of breast cancer. Modern imaging technologies include 2D mammography, digital breast tomosynthesis (3D mammography), breast MRI, breast ultrasound, molecular breast imaging, and AI-assisted diagnostic software. The growing prevalence of breast cancer, increasing government screening initiatives, technological advancements, and rising awareness regarding early diagnosis continue to drive demand for advanced breast imaging systems worldwide.
Market Trends
One of the most significant trends in the breast imaging market is the transition from conventional 2D mammography to 3D digital breast tomosynthesis, contrast-enhanced mammography, and AI-supported image interpretation. These advanced technologies improve lesion detection, reduce tissue overlap, and enhance diagnostic confidence while minimizing unnecessary recalls.
Artificial intelligence is becoming increasingly integrated into breast imaging workflows by assisting radiologists in breast density assessment, lesion detection, risk evaluation, and faster interpretation. Manufacturers are continuously introducing innovative imaging systems featuring improved image quality, automated workflows, and enhanced clinical efficiency.
Market Drivers
The rising incidence of breast cancer remains the primary factor driving market growth. Increasing awareness regarding early diagnosis and routine screening has significantly increased the demand for mammography systems, breast MRI, ultrasound, and other advanced imaging technologies.
According to the report, the American Cancer Society estimated approximately 382,640 new breast cancer cases in the U.S. in January 2026, highlighting the growing need for efficient screening and diagnostic solutions. Governments, healthcare providers, and diagnostic centers continue expanding screening programs to improve early detection and patient outcomes, further supporting market expansion.
Market Restraints
Despite growing demand, high equipment costs continue to limit market penetration, particularly in developing countries and smaller healthcare facilities. Premium imaging technologies such as digital breast tomosynthesis, breast MRI, contrast-enhanced mammography, and AI-enabled systems require significant capital investment as well as ongoing maintenance costs.
Patient concerns regarding radiation exposure and discomfort associated with mammography procedures also reduce participation in regular screening programs. Additionally, affordability remains a major barrier for healthcare providers operating under limited budgets.
Market Opportunities
The integration of artificial intelligence and workflow automation presents substantial opportunities for market participants. AI-powered software is improving radiology workflows by supporting automated lesion detection, breast density analysis, risk prediction, and faster image interpretation.
Collaborations between imaging companies and technology providers continue to accelerate AI adoption. These innovations are helping healthcare organizations improve diagnostic accuracy, reduce radiologist workload, and manage increasing screening volumes more efficiently.
Market Challenges
A major challenge facing the breast imaging market is the shortage of trained radiologists and imaging technologists. Advanced imaging systems require skilled professionals for accurate image acquisition and interpretation. Many countries continue to experience workforce shortages, delaying diagnosis and limiting access to breast screening services, particularly in underserved regions.
Market Segmentation
Based on imaging modality, 2D mammography accounted for the largest market share in 2025 due to its extensive installed base, affordability, and established reimbursement policies across hospitals and screening programs. However, the digital breast tomosynthesis segment is expected to witness the fastest growth during the forecast period owing to its superior diagnostic capabilities.
By technology, ionizing breast imaging dominated the market in 2025 and is expected to maintain its leadership due to the widespread use of digital mammography and tomosynthesis in breast cancer screening. The non-ionizing imaging segment, including breast MRI and ultrasound, is also expected to experience healthy growth.
Among end users, hospitals remained the leading segment in 2025 because of higher patient volumes, greater investment capacity, and access to advanced imaging infrastructure. Diagnostic imaging centers are also expanding rapidly due to increasing outpatient screening services.
Regional Outlook
North America remained the largest regional market with a valuation of USD 2.64 billion in 2025. Strong reimbursement policies, high awareness of breast cancer screening, and widespread deployment of 3D mammography systems continue to support regional growth. The U.S. market is projected to reach USD 2.65 billion in 2026, accounting for approximately 41.1% of global revenues.
Europe is expected to remain the second-largest market, reaching USD 1.49 billion in 2026, supported by well-developed healthcare systems and organized national screening programs. Germany and the U.K. continue to invest heavily in advanced breast imaging technologies.
Asia Pacific is projected to reach USD 1.32 billion in 2026, driven by increasing breast cancer awareness, expanding healthcare infrastructure, and growing adoption of digital mammography systems. China, Japan, and India are expected to remain key growth markets due to their large patient populations and improving diagnostic capabilities.
Latin America and the Middle East & Africa are also witnessing gradual growth as governments expand breast cancer screening programs and private diagnostic centers continue investing in digital imaging equipment.
Competitive Landscape
The breast imaging market remains highly competitive, with innovation focused on AI-assisted diagnosis, advanced mammography systems, and improved imaging workflows. Leading companies continue expanding their product portfolios through technological innovation, strategic collaborations, acquisitions, and geographic expansion.
Major companies operating in the market include Hologic, Inc., GE HealthCare, Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Canon Inc., Shanghai United Imaging Healthcare Co., LTD, Planmed Oy, IMS Giotto S.p.A., and Metaltronica S.p.A.
Key Industry Developments
Several strategic developments are strengthening market growth. In November 2025, GE HealthCare received FDA approval for its AI-powered Pristina Recon DL 3D mammography reconstruction application. ScreenPoint Medical was selected for the USD 16.0 million PRISM randomized clinical trial in September 2025. In April 2025, SimonMed partnered with Lunit and Volpara to expand AI-powered breast cancer detection across its imaging network. Earlier, Siemens Healthineers obtained FDA approval for the MAMMOMAT B.brilliant tomosynthesis platform, while GE HealthCare launched its MyBreastAI Suite to enhance AI-driven mammography interpretation.
Conclusion
The breast imaging market is expected to experience steady growth as healthcare systems worldwide continue prioritizing early breast cancer detection and advanced diagnostic technologies. Rising adoption of 3D mammography, AI-powered imaging solutions, workflow automation, and digital screening platforms will continue transforming breast cancer diagnosis. With the market expanding from USD 6.03 billion in 2025 to USD 6.66 billion in 2026 and projected to reach USD 10.63 billion by 2034, ongoing technological innovation, expanding screening programs, and increasing awareness of early diagnosis will remain the primary drivers supporting long-term market growth.
Segmentation By Imaging Modality, Technology, End-user, and Region
By Imaging Modality * 2D Mammography
- Digital Breast Tomosynthesis
- Breast Ultrasound
- Breast MRI
- Nuclear Breast Imaging
- Galactography/Ductography
- Others
By Technology * Ionizing Breast Imaging
- Non-ionizing Breast Imaging
By End-user * Hospitals
- Specialty Clinics
- Diagnostic Imaging Centers
- Others
By Region * North America (By Imaging Modality, Technology, End-user, and Country)
- U.S. (Imaging Modality)
- Canada (Imaging Modality)
- Europe (By Imaging Modality, Technology, End-user, and Country/Sub-region)
- Germany (Imaging Modality)
- U.K. (Imaging Modality)
- France (Imaging Modality)
- Spain (Imaging Modality)
- Italy (Imaging Modality)
- Scandinavia (Imaging Modality)
- Rest of Europe (Imaging Modality)
- Asia Pacific (By Imaging Modality, Technology, End-user, and Country/Sub-region)
- China (Imaging Modality)
- Japan (Imaging Modality)
- India (Imaging Modality)
- Australia (Imaging Modality)
- Southeast Asia (Imaging Modality)
- Rest of Asia Pacific (Imaging Modality)
- Latin America ( By Imaging Modality, Technology, End-user, and Country/Sub-region)
- Brazil (Imaging Modality)
- Mexico (Imaging Modality)
- Rest of Latin America (Imaging Modality)
- Middle East & Africa (By Imaging Modality, Technology, End-user, and Country/Sub-region)
- GCC (Imaging Modality)
- South Africa (Imaging Modality)
- Rest of Middle East & Africa (Imaging Modality)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Challenges
- 3.5. Market Trends
4. Key Insights
- 4.1. Prevalence/Incidence of Key Conditions, by Key Countries/Region, 2025
- 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.3. Advancements in Breast Imaging
5. Global Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 5.1.1. 2D Mammography
- 5.1.2. Digital Breast Tomosynthesis
- 5.1.3. Breast Ultrasound
- 5.1.4. Breast MRI
- 5.1.5. Nuclear Breast Imaging
- 5.1.6. Galactography/Ductography
- 5.1.7. Others
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Ionizing Breast Imaging
- 5.2.2. Non-ionizing Breast Imaging
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals
- 5.3.2. Specialty Clinics
- 5.3.3. Diagnostic Imaging Centers
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 6.1.1. 2D Mammography
- 6.1.2. Digital Breast Tomosynthesis
- 6.1.3. Breast Ultrasound
- 6.1.4. Breast MRI
- 6.1.5. Nuclear Breast Imaging
- 6.1.6. Galactography/Ductography
- 6.1.7. Others
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Ionizing Breast Imaging
- 6.2.2. Non-ionizing Breast Imaging
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics
- 6.3.3. Diagnostic Imaging Centers
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Imaging Modality
- 6.4.2. Canada
- 6.4.2.1. By Imaging Modality
- 6.4.1. U.S.
7. Europe Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 7.1.1. 2D Mammography
- 7.1.2. Digital Breast Tomosynthesis
- 7.1.3. Breast Ultrasound
- 7.1.4. Breast MRI
- 7.1.5. Nuclear Breast Imaging
- 7.1.6. Galactography/Ductography
- 7.1.7. Others
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Ionizing Breast Imaging
- 7.2.2. Non-ionizing Breast Imaging
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Diagnostic Imaging Centers
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Imaging Modality
- 7.4.2. Germany
- 7.4.2.1. By Imaging Modality
- 7.4.3. France
- 7.4.3.1. By Imaging Modality
- 7.4.4. Spain
- 7.4.4.1. By Imaging Modality
- 7.4.5. Italy
- 7.4.5.1. By Imaging Modality
- 7.4.6. Scandinavia
- 7.4.6.1. By Imaging Modality
- 7.4.7. Rest of Europe
- 7.4.7.1. By Imaging Modality
- 7.4.1. U.K.
8. Asia Pacific Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 8.1.1. 2D Mammography
- 8.1.2. Digital Breast Tomosynthesis
- 8.1.3. Breast Ultrasound
- 8.1.4. Breast MRI
- 8.1.5. Nuclear Breast Imaging
- 8.1.6. Galactography/Ductography
- 8.1.7. Others
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Ionizing Breast Imaging
- 8.2.2. Non-ionizing Breast Imaging
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals
- 8.3.2. Specialty Clinics
- 8.3.3. Diagnostic Imaging Centers
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Imaging Modality
- 8.4.2. China
- 8.4.2.1. By Imaging Modality
- 8.4.3. Australia
- 8.4.3.1. By Imaging Modality
- 8.4.4. India
- 8.4.4.1. By Imaging Modality
- 8.4.5. Southeast Asia
- 8.4.5.1. By Imaging Modality
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Imaging Modality
- 8.4.1. Japan
9. Latin America Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 9.1.1. 2D Mammography
- 9.1.2. Digital Breast Tomosynthesis
- 9.1.3. Breast Ultrasound
- 9.1.4. Breast MRI
- 9.1.5. Nuclear Breast Imaging
- 9.1.6. Galactography/Ductography
- 9.1.7. Others
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Ionizing Breast Imaging
- 9.2.2. Non-ionizing Breast Imaging
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Diagnostic Imaging Centers
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Imaging Modality
- 9.4.2. Mexico
- 9.4.2.1. By Imaging Modality
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Imaging Modality
- 9.4.1. Brazil
10. Middle East & Africa Breast Imaging Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Imaging Modality
- 10.1.1. 2D Mammography
- 10.1.2. Digital Breast Tomosynthesis
- 10.1.3. Breast Ultrasound
- 10.1.4. Breast MRI
- 10.1.5. Nuclear Breast Imaging
- 10.1.6. Galactography/Ductography
- 10.1.7. Others
- 10.2. Market Analysis, Insights and Forecast - By Technology
- 10.2.1. Ionizing Breast Imaging
- 10.2.2. Non-ionizing Breast Imaging
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Diagnostic Imaging Centers
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Imaging Modality
- 10.4.2. GCC
- 10.4.2.1. By Imaging Modality
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Imaging Modality
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Hologic, Inc.
- 11.2.2. GE HealthCare
- 11.2.3. Siemens Healthineers AG
- 11.2.4. FUJIFILM Holdings Corporation
- 11.2.5. Koninklijke Philips N.V.
- 11.2.6. Canon Inc.
- 11.2.7. Shanghai United Imaging Healthcare Co., LTD
- 11.2.8. Planmed Oy
- 11.2.9. IMS Giotto S.p.A
- 11.2.10. Metaltronica S.p.A.
List of Tables
- Table 1: Global Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 2: Global Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 3: Global Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 4: Global Breast Imaging Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 6: North America Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 7: North America Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 8: North America Breast Imaging Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 9: U.S. Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 10: Canada Breast Imaging Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
- Table 11: Europe Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 12: Europe Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 13: Europe Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 14: Europe Breast Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: Germany Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 16: U.K. Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 17: France Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 18: Italy Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 19: Spain Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 20: Scandinavia Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 21: Rest of Europe Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 22: Asia Pacific Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 23: Asia Pacific Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 24: Asia Pacific Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 25: Asia Pacific Breast Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: China Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 27: India Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 28: Japan Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 29: Australia Pacific Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 30: Southeast Asia Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 31: Rest of Asia Pacific Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 32: Latin America Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 33: Latin America Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 34: Latin America Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 35: Latin America Breast Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Brazil Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 37: Mexico Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 38: Rest of Latin America Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 39: Middle East & Africa Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 40: Middle East & Africa Breast Imaging Market Revenue (USD billion) Forecast, by Technology, 2021-2034
- Table 41: Middle East & Africa Breast Imaging Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 42: Middle East & Africa Breast Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 43: GCC Breast Imaging Market Revenue (USD billion) Forecast, by Imaging Modality, 2021-2034
- Table 44: South Africa Breast Imaging Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
- Table 45: Rest of Middle East & Africa Breast Imaging Market Revenue (USD billion) Forecast, By Imaging Modality, 2021-2034
List of Figures
- Figure 1: Global Breast Imaging Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Breast Imaging Market Value Share (%), by Imaging Modality, 2025 & 2034
- Figure 3: Global Breast Imaging Market Value Share (%), by Technology, 2025 & 2034
- Figure 4: Global Breast Imaging Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Breast Imaging Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Breast Imaging Market Value (USD billion), by Imaging Modality, 2025 & 2034
- Figure 7: North America Breast Imaging Market Value Share (%), by Imaging Modality, 2025
- Figure 8: North America Breast Imaging Market Value (USD billion), by Technology, 2025 & 2034
- Figure 9: North America Breast Imaging Market Value Share (%), by Technology, 2025
- Figure 10: North America Breast Imaging Market Value (USD billion), by End-user, 2025 & 2034
- Figure 11: North America Breast Imaging Market Value Share (%), by End-user, 2025
- Figure 12: North America Breast Imaging Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Breast Imaging Market Value Share (%), By Country, 2025
- Figure 14: Europe Breast Imaging Market Value (USD billion), by Imaging Modality, 2025 & 2034
- Figure 15: Europe Breast Imaging Market Value Share (%), by Imaging Modality, 2025
- Figure 16: Europe Breast Imaging Market Value (USD billion), by Technology, 2025 & 2034
- Figure 17: Europe Breast Imaging Market Value Share (%), by Technology, 2025
- Figure 18: Europe Breast Imaging Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Breast Imaging Market Value Share (%), by End-user, 2025
- Figure 20: Europe Breast Imaging Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 21: Europe Breast Imaging Market Value Share (%), By Country/Sub-region, 2025
- Figure 22: Asia Pacific Breast Imaging Market Value (USD billion), by Imaging Modality, 2025 & 2034
- Figure 23: Asia Pacific Breast Imaging Market Value Share (%), by Imaging Modality, 2025
- Figure 24: Asia Pacific Breast Imaging Market Value (USD billion), by Technology, 2025 & 2034
- Figure 25: Asia Pacific Breast Imaging Market Value Share (%), by Technology, 2025
- Figure 26: Asia Pacific Breast Imaging Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Breast Imaging Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Breast Imaging Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Breast Imaging Market Value Share (%), By Country/Sub-region, 2025
- Figure 30: Latin America Breast Imaging Market Value (USD billion), by Imaging Modality, 2025 & 2034
- Figure 31: Latin America Breast Imaging Market Value Share (%), by Imaging Modality, 2025
- Figure 32: Latin America Breast Imaging Market Value (USD billion), by Technology, 2025 & 2034
- Figure 33: Latin America Breast Imaging Market Value Share (%), by Technology, 2025
- Figure 34: Latin America Breast Imaging Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Breast Imaging Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Breast Imaging Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 37: Latin America Breast Imaging Market Value Share (%), By Country/Sub-region, 2025
- Figure 38: Middle East & Africa Breast Imaging Market Value (USD billion), by Imaging Modality, 2025 & 2034
- Figure 39: Middle East & Africa Breast Imaging Market Value Share (%), by Imaging Modality, 2025
- Figure 40: Middle East & Africa Breast Imaging Market Value (USD billion), by Technology, 2025 & 2034
- Figure 41: Middle East & Africa Breast Imaging Market Value Share (%), by Technology, 2025
- Figure 42: Middle East & Africa Breast Imaging Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Breast Imaging Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Breast Imaging Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Breast Imaging Market Value Share (%), By Country/Sub-region, 2025
- Figure 46: Global Breast Imaging Market Share (%), By Company, 2025
